Log In
Print this Print this

ready to use argatroban

  Manage Alerts
Collapse Summary General Information
Company Eagle Pharmaceuticals Inc.
DescriptionReady-to-use formulation of argatroban, a thrombin inhibitor
Molecular Target Thrombin (Factor IIa) (F2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationThrombosis
Indication DetailsTreat and prevent thrombosis in patients with or at risk for heparin-induced thrombocytopenia
Regulatory Designation
PartnerChiesi Farmaceutici S.p.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today